Kenneth C. Frazier - 04 Feb 2026 Form 4 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Role
Director
Signature
/s/ Benjamin Thorner, Attorney-in-Fact
Issuer symbol
EIKN
Transactions as of
04 Feb 2026
Net transactions value
+$1,999,998
Form type
4
Filing time
06 Feb 2026, 18:33:01 UTC
Previous filing
08 Nov 2022
Next filing
04 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FRAZIER KENNETH C Director C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE /s/ Benjamin Thorner, Attorney-in-Fact 06 Feb 2026 0001181175

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIKN Common Stock Purchase $1,999,998 +111,111 $18.00 111,111 04 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.